Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Aclarion, Inc. (NASDAQ:ACON) shares are up Thursday after the company announced that on June 3 its Nociscan cost-effectiveness abstract was presented at the International Society for the Advancement of Spine Surgery.
What To Know: The abstract revealed that Nociscan statistically dominates provocative discography (PD) because PD is both more costly and less effective.
"We are pleased with the cost-effectiveness abstract results," said Ryan Bond, chief strategy officer at Aclarion.
"We believe the results illustrating Nociscan's outperformance over provocative discography will be important to our physician customers and their patients, but will also speak clearly to the payer community, who are constantly challenged to reconcile the health outcomes achieved for the dollars they spend; the value in healthcare."
Related Link: Micron Stock Is Trading Down Today: What's Going On?
ACON Price Action: Shares of ACON were up 15.5% at $1.20 at the time of publication, according to Benzinga Pro.
Image by Gerd Altmann from Pixabay
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!